Dissociation of SERPINE1 mRNA from the translational repressor proteins Ago2 and TIA-1 upon platelet activation

Summary

Platelets play an important role in haemostasis, as well as in thrombosis and coagulation processes. They harbour a wide variety of messenger RNAs (mRNAs), that can template de novo protein synthesis, and an abundant array of microRNAs, which are known to mediate mRNA translational repression through proteins of the Argonaute (Ago) family. The relationship between platelet microRNAs and proteins capable of mediating translational repression, however, remains unclear. Here, we report that half of platelet microRNAs is associated to mRNA-regulatory Ago2 protein complexes, in various proportions. Associated to these Ago2 complexes are platelet mRNAs known to support de novo protein synthesis. Reporter gene activity assays confirmed the capacity of the platelet microRNAs, found to be associated to Ago2 complexes, to regulate translation of these platelet mRNAs through their 3’UTR. Neither the microRNA repertoire nor the microRNA composition of Ago2 complexes of human platelets changed upon activation with thrombin. However, under conditions favoring de novo synthesis of Plasminogen Activator Inhibitor-1 (PAI-1) protein, we documented a rapid dissociation of the encoding platelet SERPINE1 mRNA from Ago2 protein complexes as well as from the translational repressor protein T-cell-restricted intracellular antigen-1 (TIA-1). These findings are consistent with a scenario by which lifting of the repressive effects of Ago2 and TIA-1 protein complexes, involving a rearrangement of protein•mRNA complexes rather than disassembly of Ago2•microRNA complexes, would allow translation of SERPINE1 mRNA into PAI-1 in response to platelet activation.

Keywords

Platelet - microRNA - Argonaute 2 - mRNA - Plasminogen activator inhibitor-1 (PAI-1)

• References

• 1 Michelson AD. How platelets work: platelet function and dysfunction. J Thromb Thrombolysis 2003; 16: 7-12.
• 2 Schulz C, Massberg S. Platelets in atherosclerosis and thrombosis. Handb Exp Pharmacol 2012; (210) 111-33.
• 3 Roth GJ, Hickey MJ, Chung DW. et al. Circulating human blood platelets retain appreciable amounts of poly (A)+ RNA. Biochem Biophys Res Commun 1989; 160: 705-710.
• 4 Ts’ao CH. Rough endoplasmic reticulum and ribosomes in blood platelets. Scand J Haematol 1971; 08: 134-140.
• 5 Zimmerman GA, Weyrich AS. Signal-dependent protein synthesis by activated platelets: new pathways to altered phenotype and function. Arterioscler Thromb Vasc Biol 2008; 28: s17-s24.
• 6 Brogren H, Karlsson L, Andersson M. et al. Platelets synthesize large amounts of active plasminogen activator inhibitor 1. Blood 2004; 104: 3943-3948.
• 7 Landry P, Plante I, Ouellet DL. et al. Existence of a microRNA pathway in anucleate platelets. Nat Struct Mol Biol 2009; 16: 961-966.
• 8 Ple H, Landry P, Benham A. et al. The repertoire and features of human platelet microRNAs. PLoS One 2012; 07: e50746.
• 9 Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009; 136: 215-233.
• 10 Meister G, Landthaler M, Patkaniowska A. et al. Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs. Mol Cell 2004; 15: 185-197.
• 11 Fabian MR, Sundermeier TR, Sonenberg N. Understanding how miRNAs posttranscriptionally regulate gene expression. Prog Mol Subcell Biol 2010; 50: 1-20.
• 12 Kondkar AA, Bray MS, Leal SM. et al. VAMP8/endobrevin is overexpressed in hyperreactive human platelets: suggested role for platelet microRNA. J Thromb Haemost 2010; 08: 369-378.
• 13 Osman A, Falker K. Characterisation of human platelet microRNA by quantitative PCR coupled with an annotation network for predicted target genes. Platelets 2011; 22: 433-441.
• 14 Nagalla S, Shaw C, Kong X. et al. Platelet microRNA-mRNA coexpression profiles correlate with platelet reactivity. Blood 2011; 117: 5189-5197.
• 15 Simon LM, Edelstein LC, Nagalla S. et al. Human platelet microRNA-mRNA networks associated with age and gender revealed by integrated plateletomics. Blood 2014; 123: e37-e45.
• 16 Xu X, Gnatenko DV, Ju J. et al. Systematic analysis of microRNA fingerprints in thrombocythemic platelets using integrated platforms. Blood 2012; 120: 3575-3585.
• 17 Shi R, Ge L, Zhou X. et al. Decreased platelet miR-223 expression is associated with high on-clopidogrel platelet reactivity. Thromb Res 2013; 131: 508-513.
• 18 Laffont B, Corduan A, Ple H. et al. Activated platelets can deliver mRNA regulatory Ago2•microRNA complexes to endothelial cells via microparticles. Blood 2013; 122: 253-261.
• 19 Ple H, Maltais M, Corduan A, Rousseau G, Madore F, Provost P. Alteration of the platelet transcriptome in chronic kidney disease. Thromb Haemost 2012; 108: 605-615.
• 20 Marchand A, Proust C, Morange PE. et al. miR-421 and miR-30c inhibit SERPINE 1 gene expression in human endothelial cells. PLoS One 2012; 07: e44532.
• 21 Rehmsmeier M, Steffen P, Hochsmann M, Giegerich R. Fast and effective prediction of microRNA/target duplexes. RNA 2004; 10: 1507-1517.
• 22 Osman A, Hitzler WE, Meyer CU. et al. Effects of pathogen reduction systems on platelet microRNAs, mRNAs, activation, and function. Platelets. 2014. Epub ahead of print.
• 23 Beitzinger M, Peters L, Zhu JY. et al. Identification of human microRNA targets from isolated argonaute protein complexes. RNA Biol 2007; 04: 76-84.
• 24 Frank F, Sonenberg N, Nagar B. Structural basis for 5’-nucleotide base-specific recognition of guide RNA by human AGO2. Nature 2010; 465: 818-822.
• 25 Carthew RW, Sontheimer EJ. Origins and Mechanisms of miRNAs and siRNAs. Cell 2009; 136: 642-655.
• 26 Weyrich AS, Dixon DA, Pabla R. et al. Signal-dependent translation of a regulatory protein, Bcl-3, in activated human platelets. Proc Natl Acad Sci USA 1998; 95: 5556-5561.
• 27 Lindemann S, Tolley ND, Dixon DA. et al. Activated platelets mediate inflammatory signaling by regulated interleukin 1beta synthesis. J Cell Biol 2001; 154: 485-490.
• 28 Ginsburg D, Zeheb R, Yang AY. et al. cDNA cloning of human plasminogen activator- inhibitor from endothelial cells. J Clin Invest 1986; 78: 1673-1680.
• 29 Weyrich AS, Lindemann S, Tolley ND. et al. Change in protein phenotype without a nucleus: translational control in platelets. Semin Thromb Hemost 2004; 30: 491-498.
• 30 Srikantan S, Tominaga K, Gorospe M. Functional interplay between RNA-binding protein HuR and microRNAs. Curr Protein Pept Sci 2012; 13: 372-379.
• 31 Piecyk M, Wax S, Beck AR. et al. TIA-1 is a translational silencer that selectively regulates the expression of TNF-alpha. EMBO J 2000; 19: 4154-4163.
• 32 Kim HH, Kuwano Y, Srikantan S. et al. HuR recruits let-7/RISC to repress c-Myc expression. Genes Dev 2009; 23: 1743-1748.
• 33 Rowley JW, Oler AJ, Tolley ND. et al. Genome-wide RNA-seq analysis of human and mouse platelet transcriptomes. Blood 2011; 118: e101-e111.
• 34 Turchinovich A, Burwinkel B. Distinct AGO1 and AGO2 associated miRNA profiles in human cells and blood plasma. RNA Biol 2012; 09: 1066-1075.
• 35 Chu CY, Rana TM. Translation repression in human cells by microRNA-induced gene silencing requires RCK/p54. PLoS Biol 2006; 04: e210.
• 36 Iwasaki S, Kawamata T, Tomari Y. Drosophila argonaute1 and argonaute2 employ distinct mechanisms for translational repression. Mol Cell 2009; 34: 58-67.
• 37 Hong W, Kondkar AA, Nagalla S. et al. Transfection of human platelets with short interfering RNA. Clin Transl Sci 2011; 04: 180-182.
• 38 Lai X, Schmitz U, Gupta SK. et al. Computational analysis of target hub gene repression regulated by multiple and cooperative miRNAs. Nucleic Acids Res 2012; 40: 8818-8834.
• 39 Evangelista V, Manarini S, Di Santo A. et al. De novo synthesis of cyclooxygenase- 1 counteracts the suppression of platelet thromboxane biosynthesis by aspirin. Circ Res 2006; 98: 593-595.
• 40 Wu X, Brewer G. The regulation of mRNA stability in mammalian cells: 2.0. Gene 2012; 500: 10-21.
• 41 Kawai T, Lal A, Yang X. et al. Translational control of cytochrome c by RNAbinding proteins TIA-1 and HuR. Mol Cell Biol 2006; 26: 3295-3307.
• 42 Ho JJ, Marsden PA. Competition and collaboration between RNA-binding proteins and microRNAs. Wiley Interdiscip Rev RNA 2014; 05: 69-86.
• 43 Vasudevan S, Steitz JA. AU-rich-element-mediated upregulation of translation by FXR1 and Argonaute 2. Cell 2007; 128: 1105-1118.
• 44 Mazan-Mamczarz K, Galban S, Lopez de Silanes I. et al. RNA-binding protein HuR enhances p53 translation in response to ultraviolet light irradiation. Proc Natl Acad Sci USA 2003; 100: 8354-8359.
• 45 Bhattacharyya SN, Habermacher R, Martine U. et al. Relief of microRNA-mediated translational repression in human cells subjected to stress. Cell 2006; 125: 1111-1124.
• 46 Dixon DA, Tolley ND, Bemis-Standoli K. et al. Expression of COX-2 in plateletmonocyte interactions occurs via combinatorial regulation involving adhesion and cytokine signaling. J Clin Invest 2006; 116: 2727-2738.
• 47 Kieffer N, Guichard J, Farcet JP. et al. Biosynthesis of major platelet proteins in human blood platelets. Eur J Biochem 1987; 164: 189-195.
• 48 Thon JN, Devine DV. Translation of glycoprotein IIIa in stored blood platelets. Transfusion 2007; 47: 2260-2270.
• 49 Savini I, Catani MV, Arnone R. et al. Translational control of the ascorbic acid transporter SVCT2 in human platelets. Free Radic Biol Med 2007; 42: 608-616.
• 50 Thiele T, Steil L, Gebhard S. et al. Profiling of alterations in platelet proteins during storage of platelet concentrates. Transfusion 2007; 47: 1221-1233.